For funding opportunities related to COVID-19 see Western Research.
Other new funding opportunities:
"The YY Study Grants provide an important opportunity to advance cancer research through international collaboration. Their purpose is to enable individuals from any country to carry out cancer research projects abroad and including the opportunity to receive further training in research methods or techniques. "
Deadline: December 31, 2020Read More
"The OHF seeks to support research that will ultimately lead to new diagnostics, treatments, and a cure for Primary Hyperoxaluria and related Hyperoxaluria conditions. "
Deadline: December 15, 2020Read More
The ASRP provides grants and awards to support Canadian studies that promise new insights into causes, prevention, diagnosis, treatment and management of Alzheimer's disease and other dementias. The most favoured applications in the Proof of Concept Grants program are those which focus on challenging new directions in research into Alzheimer's disease and other dementias. The Grant will support investigators with innovative, high-risk, high-yield approaches to dementia research.
Deadline: November 6, 2020Read More
The AAOF solicits investigator-initiated applications on a wide range of research topics pertaining to orthodontics and/or craniofacial biology. The BRA is designed to assist mid-career and senior faculty in the U.S. and Canada to conduct independent research activities. Such activities are critical for academic and faculty development in orthodontic graduate programs. BRA proposals are generally expected to be either (i) small, well-defined and self-contained studies leading to publications in professional or scientific journals or (ii) pilot and feasibility studies to generate preliminary data in preparation of larger grant proposals to NIH or other research funding organizations. The decision to fund any given BRA application is based on scientific merit and available funds.
Deadline: November 13, 2020Read More
"Ataxia Canada funds relevant research where ataxia is the primary symptom and is genetic (recessive, dominant) and progressive in nature. This includes conditions such as Friedreich `s ataxia (FA), Beauce's ataxia (SCAR8, ARCA1), spinocerebellar ataxias (SCA), ataxias with oculomotor apraxia (AOA1-4), episodic ataxias and other cerebellar ataxias. "
Deadline:October 30, 2020Read More
"The Canadian Hemophilia Society - Bayer ADVANCE Canada Research Program was created to engage Canadian hemophilia treaters in activities to identify and research key issues in the ageing hemophilia population. The research program will support studies that aim to: - Identify and provide insight into key issues associated with the ageing hemophilia population - Identify how management of age-related co-morbidities should be adapted to those with hemophilia - Create and deliver evidence-based information to health care practitioners (HCPs), the public and policy makers that will lead to improved care and QoL for older Canadians living with hemophilia "
Deadline: November 16, 2020Read More
"Supporting research towards improving the health and the quality of life of all people with inherited bleeding disorders and finding a cure have been goals of the Canadian Hemophilia Society (CHS) since it was founded in 1953. Since 1990 through funds provided by the Hemophilia Research Million Dollar Club and the CHS, the CHS provides basic scientific research grants and studentships aimed at developing treatments for hemophilia A and B, von Willebrand disease, rare factor deficiencies, platelet function disorders and ultimately, at finding a cure. "
Deadline: November 15, 2020Read More
This program allows Canadian investigators to conduct research on medical and psychosocial aspects of bleeding disorders, including outcome evaluation. Grants are awarded for clinical research in fields relevant to improving the quality of life for persons with hemophilia, persons with von Willebrand disease or other inherited bleeding disorders, persons with related conditions such as HIV or hepatitis C, and carriers of an inherited bleeding disorder.
Deadline: November 16, 2020Read More
"The Cancer Research Institute Clinic and Laboratory Integration Program (CLIP) supports pre-clinical and translational research that can be directly applied to optimizing cancer immunotherapy in the clinic. CLIP grants are awarded to qualified scientists exploring clinically relevant questions aimed at improving the effectiveness of cancer immunotherapies. Proposals in all cancers are encouraged. "
"Deadline for letter of intent: November 1, 2020 Deadline for application: February 1, 2021"Read More
"To support these needs and complement the existing in vivo program, the Foundation is now offering a new in vitro drug screening service to rapidly assess new drugs and combination approaches. Nominated drugs can be tested for their effects on chordoma cell viability in a number of validated cell lines in a rapid and efficient manner through a centralized laboratory. Additional assay formats including cell killing and mechanistic readouts will be considered. "
Deadline: ContinuousRead More
"The Foundation's support of health research is offered in through the following programs:
- Health Research Grants
- Healthcare Research by Community Physicians
- Educational Fellowships for Practicing Physicians
- Resident Research Grants
- P.S.I.F. Fellowship for Translational Research
"Deadline: Continuous Note: Applications to PSI Foundation from London researchers are generally submitted through the Lawson Health Research Institute. Contact Lawson <email@example.com> for more information."Read More
Last updated: October 13, 2020
Western researchers can consult Pivot , a comprehensive database of grant information.